AAAAAA
Results:
1-14
|
Results: 14
Authors:
Kaynak, K
Besirli, K
Arslan, C
Ozguroglu, M
Oz, B
Citation: K. Kaynak et al., Metastatic cardiac myxoma, ANN THORAC, 72(2), 2001, pp. 623-625
Authors:
Ozguroglu, M
Arun, B
Demir, G
Demirelli, F
Mandell, NM
Buyukunal, E
Serdengecti, S
Berkarda, B
Citation: M. Ozguroglu et al., Serum erythropoietin level in anemic cancer patients, MED ONCOL, 17(1), 2000, pp. 29-34
Authors:
Ozguroglu, M
Aki, H
Demir, G
Demirelli, F
Mandel, NM
Citation: M. Ozguroglu et al., Unusual manifestations of B-cell disorders - Case 1: Multiple myeloma withpredominant phalangeal involvement, J CL ONCOL, 17(3), 1999, pp. 1083-1084
Authors:
Ozguroglu, M
Turna, H
Demir, G
Doventas, A
Demirelli, F
Mandel, NM
Buyukunal, E
Serdengecti, S
Berkarda, B
Citation: M. Ozguroglu et al., Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma, AM J CL ONC, 22(6), 1999, pp. 615-618
Authors:
Ozguroglu, M
Tahan, V
Ozguroglu, E
Ozaras, R
Demir, G
Citation: M. Ozguroglu et al., Paraneoplastic hyperpigmentation secondary to lung cancer resolving after chemotherapy, AM J CL ONC, 22(5), 1999, pp. 533-534
Authors:
Ozguroglu, M
Ersavasti, G
Ilvan, S
Hatemi, G
Demir, G
Demirelli, FH
Citation: M. Ozguroglu et al., Bilateral inflammatory breast metastases of epithelial ovarian cancer, AM J CL ONC, 22(4), 1999, pp. 408-410
Authors:
Ozguroglu, M
Demir, G
Demirelli, F
Mandel, NM
Citation: M. Ozguroglu et al., Anaphylaxis from intraperitoneal infusion of cisplatin - A case report, AM J CL ONC, 22(2), 1999, pp. 172-173
Authors:
Ozguroglu, M
Demirelli, F
Mandel, NM
Citation: M. Ozguroglu et al., Microangiopathic hemolytic anemia as an early predictor of recurrence in gastric cancer, AM J CL ONC, 22(2), 1999, pp. 214-214
Authors:
Demir, G
Ozguroglu, M
Sayhan, N
Molinas-Mandel, N
Demirelli, F
Buyukunal, E
Tuzuner, N
Serdengecti, S
Berkarda, B
Citation: G. Demir et al., Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study), ANTICANC R, 19(4C), 1999, pp. 3517-3520
Authors:
Ozguroglu, M
Ozaras, R
Tahan, V
Demirkesen, C
Demir, G
Dogusoy, G
Buyukunal, E
Serdengecti, S
Berkarda, B
Citation: M. Ozguroglu et al., Anorectal melanoma metastatic to the breast, J CLIN GAST, 29(2), 1999, pp. 197-199
Authors:
Ozguroglu, M
Celik, AF
Demir, G
Aki, H
Demirelli, F
Mandel, N
Buyukunal, E
Serdengecti, S
Berkarda, B
Citation: M. Ozguroglu et al., Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma- Mimicking metastatic tumor on abdominal CT, J CLIN GAST, 29(1), 1999, pp. 96-98
Authors:
Ozguroglu, M
Demir, G
Citation: M. Ozguroglu et G. Demir, Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma, CANCER, 86(3), 1999, pp. 547-549
Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma
Authors:
Demir, G
Demirelli, F
Ozguroglu, M
Molinas-Mandel, N
Buyukunal, E
Tuzuner, N
Serdengecti, S
Berkarda, B
Citation: G. Demir et al., Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma, INT J IMM T, 14(3), 1998, pp. 163-168
Authors:
Icli, F
Celik, I
Aykan, F
Uner, A
Demirkazik, A
Ozet, A
Ozguroglu, M
Tas, F
Akbulut, H
Firat, D
Citation: F. Icli et al., A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma, CANCER, 83(12), 1998, pp. 2475-2480
Risultati:
1-14
|